WallStreetZenWallStreetZen

NASDAQ: SYBX
Synlogic Inc Stock

$1.49+0.04 (+2.76%)
Updated Jul 12, 2024
SYBX Price
$1.49
Fair Value Price
N/A
Market Cap
$17.44M
52 Week Low
$1.35
52 Week High
$8.85
P/E
-0.19x
P/B
1.31x
P/S
6.78x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.21M
Earnings
-$73.22M
Gross Margin
100%
Operating Margin
-2,284.24%
Profit Margin
-2,284.7%
Debt to Equity
1.71
Operating Cash Flow
-$46M
Beta
1.19
Next Earnings
Aug 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

SYBX Overview

Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase II clinical trials to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate to treat homocystinuria; and SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase I clinical trial for the treatment of enteric hyperoxaluria. The company is also developing SYNB1891, an intratumorally administered synthetic biotic medicine that is in Phase I clinical trial to treat solid tumors and lymphoma. It has a collaboration agreement with F. Hoffmann-La Roche Ltd; Hoffmann-La Roche Inc.; and Ginkgo Bioworks, Inc. Synlogic, Inc. is headquartered in Cambridge, Massachusetts.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SYBX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SYBX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SYBX is good value based on its book value relative to its share price (1.31x), compared to the US Biotechnology industry average (6.45x)
P/B vs Industry Valuation
SYBX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SYBX due diligence checks available for Premium users.

Be the first to know about important SYBX news, forecast changes, insider trades & much more!

SYBX News

Valuation

SYBX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.19x
Industry
-12.81x
Market
32.2x

SYBX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.31x
Industry
6.45x
SYBX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SYBX's financial health

Profit margin

Revenue
$8.0k
Net Income
-$31.6M
Profit Margin
-394,550%
SYBX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SYBX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$36.1M
Liabilities
$22.7M
Debt to equity
1.71
SYBX's short-term assets ($34.95M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SYBX's short-term assets ($34.95M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SYBX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
SYBX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$15.4M
Investing
$16.3M
Financing
$16.0k
SYBX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SYBX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
SYBX$17.44M+2.76%-0.19x1.31x
APLM$17.54M-2.97%-0.08x0.43x
PMCB$17.61M+0.97%-1.73x0.56x
LYRA$17.74M-0.34%-0.24x0.23x
SNSE$18.18M+3.57%-0.60x0.31x

Synlogic Stock FAQ

What is Synlogic's quote symbol?

(NASDAQ: SYBX) Synlogic trades on the NASDAQ under the ticker symbol SYBX. Synlogic stock quotes can also be displayed as NASDAQ: SYBX.

If you're new to stock investing, here's how to buy Synlogic stock.

What is the 52 week high and low for Synlogic (NASDAQ: SYBX)?

(NASDAQ: SYBX) Synlogic's 52-week high was $8.85, and its 52-week low was $1.35. It is currently -83.16% from its 52-week high and 10.37% from its 52-week low.

How much is Synlogic stock worth today?

(NASDAQ: SYBX) Synlogic currently has 11,707,011 outstanding shares. With Synlogic stock trading at $1.49 per share, the total value of Synlogic stock (market capitalization) is $17.44M.

Synlogic stock was originally listed at a price of $740.25 in Oct 1, 2015. If you had invested in Synlogic stock at $740.25, your return over the last 8 years would have been -99.8%, for an annualized return of -53.98% (not including any dividends or dividend reinvestments).

How much is Synlogic's stock price per share?

(NASDAQ: SYBX) Synlogic stock price per share is $1.49 today (as of Jul 12, 2024).

What is Synlogic's Market Cap?

(NASDAQ: SYBX) Synlogic's market cap is $17.44M, as of Jul 15, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Synlogic's market cap is calculated by multiplying SYBX's current stock price of $1.49 by SYBX's total outstanding shares of 11,707,011.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.